Cited by 382Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsPhagocytosis and Immune Regulation

The DOI matches its Crossref record; 137 of the 142 references it cites were found in a registry or an index.

Microglia and inflammatory mechanisms in the clearance of amyloid β peptide

Open access

Rogers, Joseph, Strohmeyer, Ron, Kovelowski, C.J., Li, Rena·2002·Glia

DOI 10.1002/glia.10153

Open this paper in CoChat — free account Open PDF

Abstract

There is now abundant evidence that brain microglia, when activated, have the lineage, receptors, and synthetic capacity to participate in both potentially neurotoxic inflammatory responses and potentially beneficial phagocytic responses. Amyloid beta peptide (Abeta) forms highly insoluble, beta-pleated aggregates that are widely deposited in the Alzheimer's disease (AD) cortex and limbic system. Aggregated Abeta also activates the classical and alternative complement cascades. These properties make Abeta an excellent target for microglial phagocytosis, a view supported by multiple reports, through well established mechanisms of phagocyte clearance.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/glia.10153

Cites

137 of 137 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Cellular and Molecular Immunology
Abbas, A. K., Lichtman, A. H., & Pillai, S. S. (1994) · Cited by 3,571
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C. A., Hardy, J., Duff, K., Jantzen, P. T., DiCarlo, G., Wilcock, D. M., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,506
Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease
Janus, C., Pearson, J., McLaurin, J., Mathews, P. M., Jiang, Y., Schmidt, S. D., Chishti, M. A., Horne, P., Heslin, D., French, J., et al. (2000) · Nature · doi:10.1038/35050110 · Cited by 1,431
Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388 · cited 1×
“Alternatively, certain NSAIDs may either decrease A formation or promote A clearance, or both (Lee and Wurtman, 2000; Lim et al., 2000; Blasko et al., 2001; Weggen et al., 2001).”
Background
Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies
McGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
DeMattos, R. B., Bales, K. R., Cummins, D. J., Dodart, J.-C., Paul, S. M., & Holtzman, D. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151261398 · Cited by 1,298
Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain
Perry, V. H., Hume, D. A., & Gordon, S. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90215-5 · Cited by 902
Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease
Lim, G. P., Yang, F., Chu, T., Chen, P., Beech, W. K., Teter, B., Tran, T., Ubeda, O. J., Ashe, K. H., Frautschy, S. A., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05709.2000 · Cited by 876
Complement activation by beta-amyloid in Alzheimer disease.
Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., & Ward, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10016 · Cited by 817
Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease
Rogers, J., Luber-Narod, J., Styren, S. D., & Civin, W. H. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80079-4 · Cited by 743
A learning deficit related to age and β-amyloid plaques in a mouse model of Alzheimer's disease
Chen, G., Chen, K. S., Knox, J., Inglis, J., Bernard, A., Martin, S. J., Justice, A., McConlogue, L., Games, D., Freedman, S. B., et al. (2000) · Nature · doi:10.1038/35050103 · Cited by 740
Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils
Khoury, J. E., Hickman, S. E., Thomas, C. A., Cao, L., Silverstein, S. C., & Loike, J. D. (1996) · Nature · doi:10.1038/382716a0 · Cited by 727
Unusual spectral energy distribution of a galaxy previously reported to be at redshift 6.68
Chen, H., Lanzetta, K. M., Pascarelle, S. M., & Yahata, N. (2000) · RePEc: Research Papers in Economics · Cited by 680
Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease
Kaltschmidt, B., Uherek, M., Volk, B., Baeuerle, P. A., & Kaltschmidt, C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2642 · Cited by 619
Water-soluble Aβ(N-40, N-42) oligomers in normal and Alzheimer disease brains
Kuo, Y.-M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J., & Roher, A. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4077 · Cited by 618
Microglial response to amyloid plaques in APPsw transgenic mice.
Frautschy, S. A., Yang, F., Irrizarry, M., Hyman, B. T., Saido, T. C., Hsiao, K., & Cole, G. M. (1998) · Europe PMC (PubMed Central) · Cited by 592
Immune System Response in Alzheimer's Disease
McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100029863 · Cited by 460
Involvement of Microglial Receptor for Advanced Glycation Endproducts (RAGE) in Alzheimer's Disease: Identification of a Cellular Activation Mechanism
Lue, L.-F., Walker, D. G., Brachova, L., Beach, T. G., Rogers, J., Schmidt, A. M., Stern, D. M., & Yan, S. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7732 · Cited by 439
Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.
Zlokovic, B. V., Martel, C. L., Matsubara, E., McComb, J. G., Zheng, G., McCluskey, R. T., Frangione, B., & Ghiso, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4229 · Cited by 430
Amyloid-β peptide–Receptor for Advanced Glycation Endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease
Yan, S. D., Zhu, H., Fu, J., Yan, S. F., Roher, A. E., Tourtellotte, W. W., Rajavashisth, T. B., Chen, X., Godman, G. C., Stern, D. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5296 · Cited by 429
Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro
Lue, L., Rydel, R. E., Brigham, E. F., Yang, L., Hampel, H. J., Murphy, G. M., Brachova, L., Yan, S., Walker, D. G., Shen, Y., et al. (2001) · Glia · doi:10.1002/glia.1072 · Cited by 392
Activation of the classical complement pathway in brain tissue of Alzheimer patients
McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90843-4 · Cited by 383
Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells
Graeber, M. B., Streit, W. J., & Kreutzberg, G. W. (1988) · Journal of Neuroscience Research · doi:10.1002/jnr.490210104 · Cited by 367
Fibrillar β-Amyloid Induces Microglial Phagocytosis, Expression of Inducible Nitric Oxide Synthase, and Loss of a Select Population of Neurons in the Rat CNS In Vivo
Weldon, D. T., Rogers, S. D., Ghilardi, J. R., Finke, M. P., Cleary, J. P., O’Hare, E., Esler, W. P., Maggio, J. E., & Mantyh, P. W. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-02161.1998 · Cited by 348
Association of Microglia with Amyloid Plaques in Brains of APP23 Transgenic Mice
Stalder, M., Phinney, A., Probst, A., Sommer, B., Staufenbiel, M., & Jucker, M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65423-5 · Cited by 345
beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain.
Jiang, H., Burdick, D., Glabe, C. G., Cotman, C. W., & Tenner, A. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.10.5050 · Cited by 330 · cited 3×
“…activator of both the alternative and classical pathways (McGeer et al., 1989b; Eikelenboom et al., 1989; Rogers et al., 1992a, b; Jiang et al., 1994; Webster et al., 1997b, c; Lue et al., 1997; Cribbs et al., 1997; Daly and Kotwal, 1998), a result that has been extended to…”
BackgroundInfluential
The Lack of Accumulation of Senile Plaques or Amyloid Burden in Alzheimer's Disease Suggests a Dynamic Balance Between Amyloid Deposition and Resolution
Hyman, B., Marzloff, K., & Arriagada, P. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199311000-00006 · Cited by 294
Complement activation in amyloid plaques in Alzheimer’s dementia
Eikelenboom, P., Hack, C. E., Rozemüller, A. J. M., & Stam, F. C. (1988) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890024 · Cited by 288
The role of Aβ42 in Alzheimer's disease
Younkin, S. G. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(98)80035-1 · Cited by 282
Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce ?-amyloid fibrils
Frackowiak, J., Wisniewski, H. M., Wegiel, J., Merz, G. S., Iqbal, K., & Wang, K. C. (1992) · Acta Neuropathologica · doi:10.1007/bf00227813 · Cited by 276
Immunization with a Nontoxic/Nonfibrillar Amyloid-β Homologous Peptide Reduces Alzheimer's Disease-Associated Pathology in Transgenic Mice
Sigurdsson, E. M., Scholtzova, H., Mehta, P. D., Frangione, B., & Wısnıewskı, T. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61715-4 · Cited by 260
Molecular and Cellular Characterization of the Membrane Attack Complex, C5b-9, in Alzheimer’s Disease
Webster, S. D., Lue, L., Brachova, L., Tenner, A. J., McGeer, P. L., Terai, K., Walker, D. G., Bradt, B. M., Cooper, N. R., & Rogers, J. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00042-0 · Cited by 258
Complement-dependent Proinflammatory Properties of the Alzheimer's Disease β-Peptide
Bradt, B. M., Kolb, W. P., & Cooper, N. R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.3.431 · Cited by 255
Amyloid-β Induces Chemokine Secretion and Monocyte Migration across a Human Blood-Brain Barrier Model
Fiala, M., Zhang, L., Gan, X.-H., Sherry, B. A., Taub, D. D., Graves, M. C., Hama, S., Way, D., Weinand, M. E., Witte, M. H., et al. (1998) · Molecular Medicine · doi:10.1007/bf03401753 · Cited by 250
Complement and cytokine gene expression in cultured microglia derived from postmortem human brains
Walker, D. G., Kim, S. U., & McGeer, P. L. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490400407 · Cited by 248
Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.
Cooper, N. R., Jensen, F. C., Welsh, R. M., & Oldstone, M. B. A. (1976) · The Journal of Experimental Medicine · doi:10.1084/jem.144.4.970 · Cited by 245
Microglial chemotaxis, activation, and phagocytosis of amyloid β-peptide as linked phenomena in Alzheimer's disease
Rogers, J., & Lue, L.-F. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00040-7 · Cited by 236
Self-citation
Amyloid-beta induces chemokine secretion and monocyte migration across a human blood--brain barrier model.
Fiala, M., Zhang, L., Gan, X.-H., Sherry, B. A., Taub, D. D., Graves, M. C., Hama, S., Way, D., Weinand, M. E., Witte, M. H., et al. (1998) · PubMed Central · Cited by 229
MHC class II‐positive microglia in human brain: Association with alzheimer lesions
Perlmutter, L. S., Scott, S. A., Barrón, E., & Chui, H. C. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490330407 · Cited by 228
The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis.
Gasque, P., Singhrao, S., Neal, J. W., Wang, P., Sayah, S., Fontaine, M., & Morgan, B. (1998) · Journal of Immunology · doi:10.4049/jimmunol.160.7.3543 · Cited by 227
Fate of Cerebrospinal Fluid‐Borne Amyloid β‐Peptide: Rapid Clearance into Blood and Appreciable Accumulation by Cerebral Arteries
Ghersi‐Egea, J. ‐., Gorevic, P. D., Ghiso, J., Frangione, B., Patlak, C. S., & Fenstermacher, J. D. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67020880.x · Cited by 222 · cited 1×
“, 2000), and that exogenous A is rapidly transported from CSF to plasma with an elimination half-life of some 30 min (Ghersi-Egea et al., 1996; Shibata et al., 2000).”
Background
Enhancement of immunoreactivity for NF-κB in the hippocampal formation and cerebral cortex of Alzheimer's disease
Terai, K., Matsuo, A., & McGeer, P. L. (1996) · Brain Research · doi:10.1016/0006-8993(96)00310-1 · Cited by 215
Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain.
Shen, Y., Li, R.-N., Mcgeer, E., & McGeer, P. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00850-0 · Cited by 213
Chemotaxis by a CNS macrophage, the microglia
Yao, J., Harvath, L., Gilbert, D. L., & Colton, C. A. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490270106 · Cited by 212
Increased Expression of Cyclooxygenases and Peroxisome Proliferator-Activated Receptor-γ in Alzheimer's Disease Brains
Kitamura, Y., Shimohama, S., Koike, H., Kakimura, J., Matsuoka, Y., Nomura, Y., Gebicke‐Haerter, P. J., & Taniguchi, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9981 · Cited by 208
Amyloid β and Amylin Fibrils Induce Increases in Proinflammatory Cytokine and Chemokine Production by THP‐1 Cells and Murine Microglia
Yates, S. L., Burgess, L. H., Kocsis‐Angle, J., Antal, J. M., Dority, M. D., Embury, P. B., Piotrkowski, A. M., & Brunden, K. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741017.x · Cited by 202
Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia
Lacy, M., Jones, J. L., Whittemore, S. R., Haviland, D. L., Wetsel, R. A., & Barnum, S. R. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00075-d · Cited by 200
Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type
Yamamoto-Sasaki, M., Ozawa, H., Saito, T., Rösler, M., & Riederer, P. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01220-2 · Cited by 198
Physiological and pathological aspects of circulating immune complexes
Schifferli, J. A., & Taylor, R. P. (1989) · Kidney International · doi:10.1038/ki.1989.83 · Cited by 195
Molecular, cellular, and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain
Styren, S. D., Civin, W. H., & Rogers, J. (1990) · Experimental Neurology · doi:10.1016/0014-4886(90)90054-v · Cited by 191
Changes of p53 in the Brains of Patients with Alzheimer's Disease
Kitamura, Y., Shimohama, S., Kamoshima, W., Matsuoka, Y., Nomura, Y., & Taniguchi, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6301 · Cited by 185
Strong nuclear factor-?B-DNA binding parallels cyclooxygenase-2 gene transcription in aging and in sporadic alzheimer's disease superior temporal lobe neocortex
Lukiw, W. J., & Bazan, N. G. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980901)53:5 · Cited by 182
Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain
Haga, S., Akai, K., & Ishii, T. (1989) · Acta Neuropathologica · doi:10.1007/bf00687883 · Cited by 179
Complement mRNA in the mammalian brain: Responses to Alzheimer's disease and experimental brain lesioning
Johnson, S. A., Lampert-Etchells, M., Pasinetti, G. M., Rozovsky, I., & Finch, C. E. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90086-d · Cited by 176
Increased Immunoreactivity for Jun- and Fos-Related Proteins in Alzheimer's Disease: Association with Pathology
Anderson, A. J., Cummings, B. J., & Cotman, C. W. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1031 · Cited by 174
Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family
Rozemüller, A. J. M., Eikelenboom, P., Pals, S. T., & Stam, F. C. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90547-8 · Cited by 173
Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures
Lue, L. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00311-6 · Cited by 169
The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1.
Kurtz, C. B., O’Toole, E., Christensen, S. M., & Weis, J. H. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.9.3581 · Cited by 168
Complement gene expression in human brain: comparison between normal and Alzheimer disease cases
Walker, D. G., & McGeer, P. L. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90017-6 · Cited by 167
Estrogen Enhances Uptake of Amyloid β‐Protein by Microglia Derived from the Human Cortex
Li, R., Shen, Y., Yang, L., Lue, L., Finch, C. E., & Rogers, J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0751447.x · Cited by 162
A molecular and immunochemical characterization of mouse CR2. Evidence for a single gene model of mouse complement receptors 1 and 2.
Molina, H. D., Kinoshita, T., Inoue, K., Carel, J., & Holers, V. M. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.9.2974 · Cited by 158
Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid.
Frautschy, S. A., Cole, G. M., & Baird, A. (1992) · PubMed Central · Cited by 157
Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with β-amyloid[25–35]
Meda, L., Baron, P., Prat, E., Scarpini, E. A., Scarlato, G., Cassatella, M. A., & Rossi, F. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00188-x · Cited by 157
Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia
Walker, D. G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00306-2 · Cited by 155
Nuclear translocation of NF-κB in cholinergic neurons of patients with Alzheimerʼs disease
Boissière‐Michot, F., Hunot, S., Faucheux, B. A., Duyckaerts, C. J., Hauw, J., Agid, Y., & Hirsch, É. C. (1997) · Neuroreport · doi:10.1097/00001756-199709080-00009 · Cited by 152
Immune Adherence by the Fourth Component of Complement
Cooper, N. R. (1969) · Science · doi:10.1126/science.165.3891.396 · Cited by 147
APP Transgenic Mice Tg2576 Accumulate Aβ Peptides That Are Distinct from the Chemically Modified and Insoluble Peptides Deposited in Alzheimer's Disease Senile Plaques
Kalback, W. M., Watson, M. D., Kokjohn, T. A., Kuo, Y., Weiss, N., Luehrs, D. C., Lopez, J. C., Brune, D. C., Sisodia, S. S., Staufenbiel, M., et al. (2001) · Biochemistry · doi:10.1021/bi015685+ · Cited by 147
Autoantibodies to amyloid-? and Alzheimer's disease
Hyman, B. T., Smith, C. R., Buldyrev, I., Whelan, C. M., Brown, H., Tang, M., & Mayeux, R. P. (2001) · Annals of Neurology · doi:10.1002/ana.1061 · Cited by 144
Lesion of the rat entorhinal cortex leads to a rapid microglial reaction in the dentate gyrus
Gehrmann, J., Schoen, S. W., & Kreutzberg, G. W. (1991) · Acta Neuropathologica · doi:10.1007/bf00293378 · Cited by 144
Complement C1qB and C4 mRNAs responses to lesioning in rat brain
Pasinetti, G. M., Johnson, S. A., Rozovsky, I., Lampert-Etchells, M., Morgan, D., Gordon, M. N., Morgan, T. E., Willoughby, D., & Finch, C. E. (1992) · Experimental Neurology · doi:10.1016/0014-4886(92)90028-o · Cited by 138
Complement Component C1q Modulates the Phagocytosis of Aβ by Microglia
Webster, S. D., Yang, A. J., Margol, L., Garzon-Rodriguez, W., Glabe, C. G., & Tenner, A. J. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7260 · Cited by 138
Synthetic Alzheimer amyloid β/A4 peptides enhance production of complement C3 component by cultured microglial cells
Haga, S., Ikeda, K., Sato, M., & Ishii, T. (1993) · Brain Research · doi:10.1016/0006-8993(93)91698-r · Cited by 136
Brain Uptake of Circulating Apolipoproteins J and E Complexed to Alzheimer′s Amyloid β
Zloković, B. V., Martel, C. L., Mačkić, J. B., Matsubara, E., Wısnıewskı, T., McComb, J. G., Frangione, B., & Ghiso, J. A. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2825 · Cited by 133
Microglial activation in early stages of amyloid β protein deposition
Sasaki, A., Yamaguchi, H., Ogawa, A., Sugihara, S., & Nakazato, Y. (1997) · Acta Neuropathologica · doi:10.1007/s004010050713 · Cited by 132
Immune system associated antigens expressed by cells of the human central nervous system
Luber‐Narod, J., & Rogers, J. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90263-7 · Cited by 131
Complement depletion accelerates the clearance of immune complexes from the circulation of primates.
Waxman, F. J., Hebert, L. A., Cornacoff, J. B., VanAman, M. E., Smead, W. L., Kraut, E. H., Birmingham, D. J., & Taguiam, J. M. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111543 · Cited by 120
3D-Reconstruction of microglia and amyloid in APP23 transgenic mice: no evidence of intracellular amyloid
Stalder, M., Deller, T., Staufenbiel, M., & Jucker, M. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00209-3 · Cited by 118
Detection of complement alternative pathway mRNA and proteins in the Alzheimer’s disease brain
Strohmeyer, R., Shen, Y., & Rogers, J. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00149-2 · Cited by 114
The role of complement in Alzheimer’s disease pathology
Emmerling, M. R., Watson, M. D., Raby, C. A., & Spiegel, K. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00042-9 · Cited by 110
Quantitative neuronal c-Fos and c-Jun expression in Alzheimer’s disease
Marcus, D. L., Strafaci, J. A., Miller, D. C., Masiá, S., Thomas, C., Rosman, J. Z., Hussain, S., & Freedman, M. L. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00077-3 · Cited by 106
Beta-amyloid (25-35) peptide and IFN-γ synergistically induce the production of the chemotactic cytokine MCP-1/JE in monocytes and microglial cells
Meda, L., Bernasconi, S., Bonaiuto, C., Sozzani, S., Zhou, D., Otvos, L. P., Mantovani, A., Rossi, F., & Cassatella, M. A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.3.1213 · Cited by 104
Aggregation State‐Dependent Activation of the Classical Complement Pathway by the Amyloid β Peptide
Webster, S. D., Bradt, B. M., Rogers, J., & Cooper, N. R. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010388.x · Cited by 103
Alzheimer's β‐Amyloid Peptide 1–42 Induces a Phagocytic Response in Murine Microglia
Kopec, K. K., & Carroll, R. T. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71052123.x · Cited by 102
Alteration of transcription factors NF-κB and STAT1 in Alzheimer's disease brains
Kitamura, Y., Shimohama, S., Ota, T., Matsuoka, Y., Nomura, Y., & Taniguchi, T. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00797-0 · Cited by 99
Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease
Rozemüller, A. J. M., Stam, F. C., & Eikelenboom, P. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90759-3 · Cited by 98
The Clearance of Immune Complexes From the Circulation of Man and Other Primates
Hebert, L. A. (1991) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80488-4 · Cited by 98
Differential expression of individual complement regulators in the brain and choroid plexus.
Singhrao, S. K., Neal, J. W., Rushmere, N. K., Morgan, B. P., & Gasque, P. (1999) · PubMed · Cited by 95
The amyloid beta-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes
Davis, J. B., McMurray, H. F., & Schubert, D. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)92317-q · Cited by 93
SYNTHESIS AND SECRETION OF COMPLEMENT PROTEINS BY MACROPHAGES*
Colten, H. R., Ooi, Y. M., & Edelson, P. J. (1979) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1979.tb47142.x · Cited by 92
Ibuprofen Decreases Cytokine-Induced Amyloid Beta Production in Neuronal Cells
Blasko, I., Apochal, A., Boeck, G., Hartmann, T., Grubeck‐Loebenstein, B., & Ransmayr, G. N. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0451 · Cited by 92
Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue
Overmyer, M., Helisalmi, S., Soininen, H., Laakso, M., Riekkinen Sr., P., & Alafuzoff, I. (1999) · Acta Neuropathologica · doi:10.1007/s004010051002 · Cited by 91
Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli.
Waxman, F. J., Hebert, L. A., Cosío, B. G., Smead, W. L., VanAman, M. E., Taguiam, J. M., & Birmingham, D. J. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112306 · Cited by 90
Expression of Fos, Jun, and Krox Family Proteins in Alzheimer's Disease
MacGibbon, G. A., Lawlor, P. A., Walton, M. R., Sirimanne, E. S., Faull, R. L. M., Synek, B. J. L., Mee, E. T., Connor, B. J., & Dragunow, M. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6600 · Cited by 86
Multivalent Binding of Complement Protein C1q to the Amyloid β-Peptide (Aβ) Promotes the Nucleation Phase of Aβ Aggregation
Webster, S., Glabe, C., & Rogers, J. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2852 · Cited by 84
Reactive microglia/macrophages phagocytose amyloid precursor protein produced by neurons following neural damage
Shigematsu, K., McGeer, P. L., Walker, D. G., Ishii, T., & McGeer, E. G. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310306 · Cited by 83
β-Peptide Immunization
Schenk, D. B., Seubert, P. A., Lieberburg, I. M., & Wallace, J. (2000) · Archives of Neurology · doi:10.1001/archneur.57.7.934 · Cited by 78
Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide.
Webster, S. M., Bonnell, B. S., & Rogers, J. (1997) · Europe PMC (PubMed Central) · Cited by 77
Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of β-amyloid protein
Akiyama, H., Schwab, C., Kondo, H., Mori, H., Kametani, F., Ikeda, K., & McGeer, P. L. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)12474-5 · Cited by 76
Chemotactic-like receptors and Aβ peptide induced responses in Alzheimer's Disease
Lorton, D. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00092-0 · Cited by 73
NF‐kB immunoreactivity is observed in association with βA4 diffuse plaques in patients with Alzheimer’s disease
Ferrer, Martí, López, & Tortosa, A. (1998) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1998.00116.x · Cited by 69
Morphogenesis of amyloid plaques in 87V murine scrapie†
Jeffrey, M., Goodsir, C. M., Bruce, M. E., McBride, P., & Farquhar, C. F. (1994) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1994.tb01007.x · Cited by 68
Analysis of C3b/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2.
Molina, H. D., Kinoshita, T., Webster, C. B., & Holers, V. M. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.2.789 · Cited by 66
Transcriptional regulation of inflammatory secreted phospholipases A2
Andréani, M., Olivier, J. L., Berenbaum, F., Raymondjean, M., & Bereziat, G. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00117-7 · Cited by 63
Identification of murine complement receptor type 2.
Fingeroth, J. D., Benedict, M., Levy, D. N., & Strominger, J. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.1.242 · Cited by 61
A Protein with Characteristics of Factor H Is Present on Rodent Platelets and Functions as the Immune Adherence Receptor
Alexander, J. J., Hack, B. K., Cunningham, P. N., & Quigg, R. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101299200 · Cited by 59
Cultured Rat Microglia Express C1q and Receptor for C1q: Implications for Amyloid Effects on Microglia
Korotzer, A. R., Watt, J. A., Cribbs, D. H., Tenner, A. J., Burdick, D., Glabe, C. G., & Cotman, C. W. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1051 · Cited by 54
Complement gene expression in mouse microglia and astrocytes in culture: comparisons with mouse peritoneal macrophages
Haga, S., Aizawa, T., Ishii, T., & Ikeda, K. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)13040-8 · Cited by 53
In vivo and in vitro studies of the binding of antibody/dsDNA immune complexes to rabbit and guinea pig platelets.
Taylor, R. P., Kujala, G. A., Wilson, K., WRIGHT, E. M., & Harbin, A. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.134.4.2550 · Cited by 49
Elimination of the Class A Scavenger Receptor Does Not Affect Amyloid Plaque Formation or Neurodegeneration in Transgenic Mice Expressing Human Amyloid Protein Precursors
Huang, F., Buttini, M., Wyss-Coray, T., McConlogue, L., Kodama, T., Pitas, R. E., & Mucke, L. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65489-2 · Cited by 49
Clearance and tissue uptake of immune complexes in complement-depleted and control mice.
Bockow, B. I., & Mannik, M. (1981) · PubMed · Cited by 45
Phagocytosis is Regulated by Nitric Oxide in Murine Microglia
Kopec, K. K., & Carroll, R. T. (2000) · Nitric Oxide · doi:10.1006/niox.2000.0280 · Cited by 44
Apoptosis of cultured microglia by the deprivation of macrophage colony-stimulating factor
Tomozawa, Y., Inoue, T., Takahashi, M., Adachil, M., & Satoh, M. (1996) · Neuroscience Research · doi:10.1016/0168-0102(96)01021-8 · Cited by 43
Activation of the Complement System
Cooper, N. R. (1973) · Springer eBooks · doi:10.1007/978-1-4684-7773-3_7 · Cited by 41
Expression of activating transcription factor-2 (ATF-2), one of the cyclic AMP response element (CRE) binding proteins, in Alzheimer disease and non-neurological brain tissues.
Yamada, T., Yoshiyama, Y., & Kawaguchi, N. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01356-x · Cited by 40
Pro-inflammatory complement activation by the Aβ peptide of Alzheimer’s disease is biologically significant and can be blocked by vaccinia virus complement control protein
Daly, J. J., & Kotwal, G. J. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00100-6 · Cited by 39
Priming of monocyte respiratory burst by β-amyloid fragment (25–35)
Meda, L., Bonaiuto, C., Baron, P., Ötvös, L., Rossi, F., & Cassatella, M. A. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13177-3 · Cited by 36
Neurological and Sensory Disorders in the Elderly
Plum, F. (1976) · Archives of Neurology · doi:10.1001/archneur.1976.00500080069018 · Cited by 36
Immune adherence and the processing of soluble complement-fixing antibody/DNA immune complexes in mice
Edberg, J. C., Tosic, L., & Taylor, R. P. (1989) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(89)90212-2 · Cited by 35
Murine complement receptor gene family. II. Identification and characterization of the murine homolog (Cr2) to human CR2 and its molecular linkage to Crry.
Kurtz, C. B., Paul, M. S., Aegerter, M., Weis, J. J., & Weis, J. H. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.6.2058 · Cited by 34
PKC and tyrosine kinase involvement in amyloid β (25-35)-induced chemotaxis of microglia
Nakai, M., Hojo, K., Taniguchi, T., Terashima, A., Kawamata, T., Hashimoto, T., Maeda, K., & Tanaka, C. (1998) · Neuroreport · doi:10.1097/00001756-199810260-00024 · Cited by 34
Regulation of APP Synthesis and Secretion by Neuroimmunophilin Ligands and Cyclooxygenase Inhibitors
Lee, R. K. K., & Wurtman, R. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06934.x · Cited by 33
beta-Amyloid, protein processing and Alzheimer's disease.
Haas, C., Hung, A. Y., Citron, M., Teplow, D. B., & Selkoe, D. J. (1995) · PubMed · Cited by 31
Possible Different Mechanism between Amyloid-Beta (25–35)- and Substance P-lnduced Chemotaxis of Murine Microglia
Maeda, K., Nakai, M., Maeda, S., Kawamata, T., Yamaguchi, T., & Tanaka, C. (2009) · Gerontology · doi:10.1159/000213881 · Cited by 26
Complement activation by cross-linked truncated and chimeric full-length β-amyloid
Cribbs, D. H., Velázquez, P., Soreghan, B. A., Glabe, C. G., & Tenner, A. J. (1997) · Neuroreport · doi:10.1097/00001756-199711100-00009 · Cited by 26
Amyloid deposition is associated with c‐Jun expression in Alzheimer's disease and amyloid angiopathy
Ferrer, I., Seguı́, J., & Planas, A. M. (1996) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1996.tb01130.x · Cited by 23
Over-expression of c-fos mRNA in the hippocampal neurons in Alzheimer's disease.
Lu, W., Mi, R., Tang, H., Liu, S., Fan, M., & Wang, L. (1998) · PubMed · Cited by 19
Elucidating Molecular Mechanisms of Alzheimer’s Disease in Microglial Cultures
Rogers, J., Lue, L., Walker, D. G., Yan, S. D., Stern, D., Strohmeyer, R., & Kovelowski, C. J. (2002) · Springer eBooks · doi:10.1007/978-3-662-05073-6_3 · Cited by 18
Complement Effector Mechanisms in Health and Disease
Cooper, N. R., & Nemerow, G. R. (1985) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12275441 · Cited by 16
The βA4 Amyloid Protein Precursor in Human Circulationa
Bush, A. I., Beyreuther, K. T., & Masters, C. L. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23048.x · Cited by 16
Complement-Mediated Solubilization of Immune Complexes and Their Interaction with Complement C3 Receptors
Petersen, I., Baatrup, G., JEPSEN, H. H., & Svehag, S. (2017) · Complement · doi:10.1159/000467850 · Cited by 13
Deficiency of complement component C3 is associated with accelerated removal of soluble 123I-labelled aggregates of IgG from the circulation
Halma, C., Daha, M. R., Camps, J. A. J., Evers-Schouten, J. H., Pauwels, E. K. J., & van Es, L. A. (1992) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb05857.x · Cited by 10
Ultrastructural and immunocytochemical studies of macrophages in an excitotoxin induced lesion in the rat brain.
Kaur, C., Yg, C., & Ea, L. (1992) · PubMed · Cited by 8
Untitled work
Ard (1996) · doi:10.1002/(sici)1097-4547(19960115)43:2

Flagged first, then by citations

5 of the 142 references couldn’t be matched to a known paper.

Research works printed but not linked: 9

Abbas A, 1994, Cellular and molecular immunology, 295
10.1084/jem.188.3.431 · DOI
10.1016/S0272-6386(12)80488-4 · DOI
10.1021/bi015685 · DOI
Kovelowski CJ, 2001, Opsonization and anti‐inflammatory drug effects on microglial chemotaxis, phagocytosis, and cytokine secretion in vitro after amyloid peptide exposure, Soc Neurosci Abstr
Lue LF, 1997, Modeling Aβ deposition in cultures of Alzheimer's glia and hnt neurons, Neurosci Abs, 23, 533
10.1002/glia.1072 · DOI
10.1073/pnas.89.21.10016 · DOI · Paper page
10.1002/jnr.490400407 · DOI

Sorted by citations

Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity
Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023
Bone Marrow-Derived Microglia Play a Critical Role in Restricting Senile Plaque Formation in Alzheimer's Disease
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Three or more routes for leukocyte migration into the central nervous system
Ransohoff, R. M., Kivisäkk, P., & Kidd, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1130 · Cited by 1,052
ApoE Promotes the Proteolytic Degradation of Aβ
Jiang, Q., Lee, C. Y. D., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T. M., Collins, J. L., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.010 · Cited by 876
The role of inflammation in Alzheimer’s disease
Tuppo, E. E., & Arias, H. R. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.07.009 · Cited by 734

See all 382

Authors: Rogers, J., Strohmeyer, R., Kovelowski, C. J., & Li, R.
Affiliations: Banner Sun Health Research Institute (US)
Corresponding author: Rogers, Joseph
ORCID: Kovelowski, C.J.
Li, Rena
Venue: Glia
Publisher: Wiley
Published: 2002-10-04
Volume: 40
Issue: 2
Pages: 260-269
ISSN: 0894-1491 (ISSN-L)
1098-1136
DOI: 10.1002/glia.10153
OpenAlex: W2046704592
Cited by: 381
References: 142
Citations by year: 2026: 6 · 2025: 10 · 2024: 9 · 2023: 6 · 2022: 10 · 2021: 15 · 2020: 9 · 2019: 11 · 2018: 12 · 2017: 8 · 2016: 12 · 2015: 14 · 2014: 19 · 2013: 17 · 2012: 18
FWCI: 1.98
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Glia (publishedVersion)
PubMed (publishedVersion)
Funders: Alzheimer's Association
National Institute on Aging (AGO7367)
Topics: Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
Keywords: microglia, amyloid-beta, Alzheimer's disease, microglial phagocytosis, neuroinflammation, complement system, microglial activation
MeSH terms: Alzheimer Disease, Animals, Antigen-Antibody Complex, Antigens, Chemotaxis, Encephalitis, Humans, Phagocytosis, Amyloid beta-Peptides, Microglia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Microglia and inflammatory mechanisms in the clearance of amyloid β peptide

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks